Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis

被引:18
作者
Bardenstein, DS
Cheyer, CJ
Lee, C
Cocuzzi, E
Mizuno, M
Okada, N
Medof, ME
机构
[1] Case Western Reserve Univ, Sch Med, Inst Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Ctr Vis Res, Cleveland, OH USA
[3] Nagoya City Univ, Sch Med, Dept Biol Mol, Nagoya, Aichi 467, Japan
关键词
D O I
10.1046/j.1365-2567.2001.01316.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The open environment of the eye is continuously subject to an influx of foreign agents that can activate complement. Decay-accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 are regulators that protect self-cells from autologous complement activation on their surfaces. They are expressed in the eye at unusually high levels but their physiological importance in this site is unstudied. In the rat, a structural analogue termed 5I2 antigen (5I2 Ag) has actions overlapping DAF and MCP. In this investigation, we injected F(ab')(2) fragments of 5I2 mAb into the conjunctiva and aqueous humor, in the latter case with and without concomitant blockage of CD59. Massive neutrophilic infiltration of the stroma and iris resulted upon blocking 5I2 Ag activity. Frank necrosis of the iris occurred upon concomitant intraocular blockage of CD59. C3b was identified immunohistochemically, and minimal effects were seen in complement-depleted animals and in those treated with non-relevant antibody. The finding that block-age of 5I2 Ag function in periocular tissues and within the eye causes intense conjunctival inflammation and iritis demonstrates the importance of intrinsic complement regulators in protecting ocular tissues from spontaneous or bystander attack by autologous complement.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 46 条
[1]  
ABBAS AK, 1997, CELLULAR MOL IMMUNOL, P313
[2]  
Antonelli A, 1996, CLIN EXP RHEUMATOL, V14, pS31
[3]   DECAY-ACCELERATING FACTOR IS PRESENT ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
ASCH, AS ;
KINOSHITA, T ;
JAFFE, EA ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (01) :221-226
[4]  
Bardenstein D. S., 1997, Investigative Ophthalmology and Visual Science, V38, pS1075
[5]  
Bardenstein DS, 2000, INVEST OPHTH VIS SCI, V41, pS673
[6]  
Bardenstein DS, 1999, INVEST OPHTH VIS SCI, V40, P519
[7]   LOCALIZATION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX INHIBITOR (CD59) IN HUMAN CONJUNCTIVA AND LACRIMAL GLAND [J].
BARDENSTEIN, DS ;
DIETZ, Y ;
LASS, JH ;
MEDOF, ME .
CURRENT EYE RESEARCH, 1994, 13 (12) :851-855
[8]  
BORA NS, 1993, INVEST OPHTH VIS SCI, V34, P3579
[9]  
Brodbeck WG, 1996, J IMMUNOL, V156, P2528
[10]   LOCALIZATION OF DECAY ACCELERATING FACTOR IN NORMAL AND DISEASED KIDNEYS [J].
COSIO, FG ;
SEDMAK, DD ;
MAHAN, JD ;
NAHMAN, NS .
KIDNEY INTERNATIONAL, 1989, 36 (01) :100-107